Communicating about Risks and Safe Use of Medicines

Priya Bahri holds degrees in pharmacy and epidemiology, focused her PhD at Humboldt University of Berlin on healthcare quality management, and is trained in strategic communication and global health diplomacy. She worked in pharmacies and for projects of health insurance physicians’ associations and the German international development agency before joining the European Medicines Agency (EMA) in 1996 and specialising in pharmacovigilance. She is active for the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation and also in learned societies, including as fellow of the International Society of Pharmacovigilance.

Foreword (Baruch Fischhoff).- Preface: Guide for readers (Priya Bahri).- Authors’ biographical notes.- Overview of contents in chapters.- 1. A multilayered research framework for humanities and epidemiology of medicinal product risk communication (Priya Bahri).- Part I: Medicines in real life as communication challenges. 2. Hormonal contraceptives - Communication for risk awareness and informed choice, or a public scare? (Barbara Mintzes, Teresa Alves, with a contribution from Priya Bahri).- 3. COX-2 inhibitors - Communication of accumulating risk evidence and a product withdrawal (Amy Rogers, Kerr Grieve, Thomas M MacDonald, with a contribution from Sérgio Nishioka).- 4. Isotretinoin - Communication for preventing birth defects and alerting of an uncertain risk of suicide (Ineke (HJMJ) Crijns).- 5. Pandemic influenza vaccines - Communication of benefits, risks and uncertainties (Glen J Nowak, Emilie Karafillakis, Heidi Larson).- Part II: Tackling the challenges – Methods for medicinal product risk communication research. 6. Ethical frameworks (Ghislaine van Thiel).- 7. The cognitive and behavioural sciences (Sara Rubinelli, Nicola Diviani, Maddalena Fiordelli).- 8. The social sciences (Brian Taylor, Anne Moorhead).- 9. Rhetoric and science & technology studies (Mathias Møllebæk).- 10. Media science and practice (Glen J Nowak, Michael A Cacciatore).- 11. Social media research (Nabarun Dasgupta, Carly Winokur, Carrie E Pierce).- 12. Design science with a focus on user-centred evaluation of written information (Jörg Fuchs).- 13. Dissemination & implementation science (Elaine Morrato, Meredith Smith).- 14. Pharmacoepidemiology (Bert (HGM) Leufkens).- 15. Legal frameworks (Burkhard Sträter).- 16. From passive to active - Patients as contributors to medicinal product risk communication research (François Houÿez).- Afterword: The dimension of communicating medicine risks in low- and middle-income countries (Nilima A Kshirsagar).